Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Lam

Showing results (571-580 of 1,163) with videos related to

Pageof 117
Sort By:
Current Medicinal Chemistry|July 16, 2011
How would composite traditional Chinese medicine protect the brain--an example of the composite formula "Pien Tze Huang"L Zhang, W P Lam, L Lü, et al.
Global Heart|June 19, 2023
Polypill Eligibility for Patients with Heart Failure with Reduced Ejection Fraction in the ASIAN-HF Registry: A Cross-Sectional AnalysisAishwarya Vijay, Wan Ting Tay, Tiew-Hwa K Teng, et al.
Journal of Cardiac Failure|May 13, 2026
Prevalence, Progression, and Prognosis of Heart Stress In the Community: Implications for Heart Failure PreventionAnping Cai, Lin Liu, Yinqing Feng, et al.
Cardiovascular Research|November 30, 2022
Phenomapping in heart failure with preserved ejection fraction: insights, limitations, and future directionsAnthony E Peters, Jasper Tromp, Sanjiv J Shah, et al.
Chest|July 4, 2014
Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose studyDiana Bonderman, Ingrid Pretsch, Regina Steringer-Mascherbauer, et al.
European Journal of Heart Failure|May 10, 2026
Ziltivekimab in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the ATHENA and HERMES trialsGuiomar Mendieta, Paul M Ridker, Barry A Borlaug, et al.
Chest|April 8, 2009
Utility of [18F]2-fluoro-2-deoxyglucose-PET in sporadic and tuberous sclerosis-associated lymphangioleiomyomatosisLisa R Young, David N Franz, Preeti Nagarkatte, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 12, 2007
An efficient and safe herpes simplex virus type 1 amplicon vector for transcriptionally targeted therapy of human hepatocellular carcinomasPaula Y P Lam, Kian Chuan Sia, Jenn H Khong, et al.
American Journal of Respiratory and Critical Care Medicine|June 13, 2014
Wnt coreceptor Lrp5 is a driver of idiopathic pulmonary fibrosisAnna P Lam, Jose D Herazo-Maya, Joseph A Sennello, et al.
ESC Heart Failure|July 3, 2020
Left atrial strain as sensitive marker of left ventricular diastolic dysfunction in heart failureAthanasios Frydas, Daniel A Morris, Evgeny Belyavskiy, et al.
Pageof 117

Showing results (571-580 of 1,163) with videos related to

Sort By:
Pageof 117
Current Medicinal Chemistry|July 16, 2011
How would composite traditional Chinese medicine protect the brain--an example of the composite formula "Pien Tze Huang"L Zhang, W P Lam, L Lü, et al.
Global Heart|June 19, 2023
Polypill Eligibility for Patients with Heart Failure with Reduced Ejection Fraction in the ASIAN-HF Registry: A Cross-Sectional AnalysisAishwarya Vijay, Wan Ting Tay, Tiew-Hwa K Teng, et al.
Journal of Cardiac Failure|May 13, 2026
Prevalence, Progression, and Prognosis of Heart Stress In the Community: Implications for Heart Failure PreventionAnping Cai, Lin Liu, Yinqing Feng, et al.
Cardiovascular Research|November 30, 2022
Phenomapping in heart failure with preserved ejection fraction: insights, limitations, and future directionsAnthony E Peters, Jasper Tromp, Sanjiv J Shah, et al.
Chest|July 4, 2014
Acute hemodynamic effects of riociguat in patients with pulmonary hypertension associated with diastolic heart failure (DILATE-1): a randomized, double-blind, placebo-controlled, single-dose studyDiana Bonderman, Ingrid Pretsch, Regina Steringer-Mascherbauer, et al.
European Journal of Heart Failure|May 10, 2026
Ziltivekimab in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the ATHENA and HERMES trialsGuiomar Mendieta, Paul M Ridker, Barry A Borlaug, et al.
Chest|April 8, 2009
Utility of [18F]2-fluoro-2-deoxyglucose-PET in sporadic and tuberous sclerosis-associated lymphangioleiomyomatosisLisa R Young, David N Franz, Preeti Nagarkatte, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 12, 2007
An efficient and safe herpes simplex virus type 1 amplicon vector for transcriptionally targeted therapy of human hepatocellular carcinomasPaula Y P Lam, Kian Chuan Sia, Jenn H Khong, et al.
American Journal of Respiratory and Critical Care Medicine|June 13, 2014
Wnt coreceptor Lrp5 is a driver of idiopathic pulmonary fibrosisAnna P Lam, Jose D Herazo-Maya, Joseph A Sennello, et al.
ESC Heart Failure|July 3, 2020
Left atrial strain as sensitive marker of left ventricular diastolic dysfunction in heart failureAthanasios Frydas, Daniel A Morris, Evgeny Belyavskiy, et al.
Pageof 117